Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 14 results:
[ Συντάκτης] Τίτλος Τύπος Έτος Φίλτρα: Συντάκτης is Panidis, Dimitrios [Clear All Filters]
Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome..
Eur J Obstet Gynecol Reprod Biol. 149(2), 170-4.
(2010). Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility..
Endocrine. 44(3), 583-90.
(2013). Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study..
Hum Reprod. 27(2), 541-9.
(2012). Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome..
Endocr Pract. 20(6), 540-7.
(2014). The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome..
Eur J Endocrinol. 168(6), 871-7.
(2013). Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels..
Med Hypotheses. 77(4), 649-53.
(2011). The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 80(3), 432-8.
(2014). Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome..
Eur J Endocrinol. 168(2), 145-52.
(2013). The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study..
Reprod Biol Endocrinol. 8, 151.
(2010). Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome..
Gynecol Endocrinol. 29(10), 926-30.
(2013). Prevalence of metabolic syndrome in women with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 78(4), 586-92.
(2013). The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia..
Gynecol Endocrinol. 27(8), 587-92.
(2011).
(2013).
(2012).